Finck C M, Hodell M G, Marx W H, Paskanik A M, McGraw D J, Lutz C J, Gatto L A, Picone A L, Nieman G F
Department of Surgery, SUNY Health Science Center at Syracuse, NY 13210-2339, USA.
Crit Care Med. 1998 Aug;26(8):1414-8. doi: 10.1097/00003246-199808000-00029.
To determine whether endotoxin-stimulated alveolar macrophages would attract neutrophils and whether exogenous surfactant treatment would modulate this chemoattraction.
Alveolar macrophages were harvested from bronchoalveolar lavage fluid and neutrophils from the blood of anesthetized guinea pigs.
Hartley guinea pigs.
Alveolar macrophages were suspended in RPMI 1640 and stimulated with 1 microg/mL of lipopolysaccharide (LPS), the supernatant removed and the alveolar macrophages were incubated in either RPMI or RPMI with surfactant at two different doses (292 microg/mL or 875 microg/mL) for 16 hrs.
The supernatant was extracted from the alveolar macrophages and placed in a chemotaxis plate and the migration of neutrophils was measured. Chemotaxis of all cell types to be tested was measured by a change of absorbance on a microplate reader set at 492 nm. Results were compared with alveolar macrophages not stimulated with LPS, RPMI alone, and N formyl-methionyl-leucyl-phenylalanine (FMLP). The supernatant of the stimulated alveolar macrophages increased neutrophil chemotaxis as compared with unstimulated alveolar macrophages, and RPMI (p < .05). Surfactant treatment with 292 microg/mL significantly decreased LPS-stimulated alveolar macrophages induced neutrophil chemotaxis. Treatment with 875 microg/mL of surfactant did not alter neutrophil chemotaxis.
Alveolar macrophages stimulation with LPS increased the chemotaxis of neutrophils. Treatment with surfactant at a concentration of 875 microg/mL did not alter neutrophil migration; however, treatment with 292 microg/mL significantly decreased neutrophil chemotaxis suggesting that at low concentrations, surfactant inhibits chemokine release and may reduce pulmonary neutrophil sequestration in vivo.
确定内毒素刺激的肺泡巨噬细胞是否会吸引中性粒细胞,以及外源性表面活性剂治疗是否会调节这种趋化作用。
从麻醉的豚鼠支气管肺泡灌洗液中获取肺泡巨噬细胞,从血液中获取中性粒细胞。
哈特利豚鼠。
将肺泡巨噬细胞悬浮于RPMI 1640中,用1微克/毫升的脂多糖(LPS)刺激,去除上清液,然后将肺泡巨噬细胞在RPMI中或在含有两种不同剂量(292微克/毫升或875微克/毫升)表面活性剂的RPMI中孵育16小时。
从肺泡巨噬细胞中提取上清液,置于趋化板中,测量中性粒细胞的迁移情况。通过在设置为492纳米的酶标仪上吸光度的变化来测量所有受试细胞类型的趋化作用。将结果与未用LPS刺激的肺泡巨噬细胞、单独的RPMI以及N-甲酰甲硫氨酰亮氨酰苯丙氨酸(FMLP)进行比较。与未刺激的肺泡巨噬细胞和RPMI相比,刺激后的肺泡巨噬细胞上清液增加了中性粒细胞的趋化作用(p < 0.05)。用292微克/毫升的表面活性剂处理可显著降低LPS刺激的肺泡巨噬细胞诱导的中性粒细胞趋化作用。用875微克/毫升的表面活性剂处理未改变中性粒细胞的趋化作用。
用LPS刺激肺泡巨噬细胞可增加中性粒细胞的趋化作用。用875微克/毫升浓度的表面活性剂处理未改变中性粒细胞的迁移;然而,用292微克/毫升处理可显著降低中性粒细胞的趋化作用,这表明在低浓度下,表面活性剂可抑制趋化因子的释放,并可能减少体内肺中性粒细胞的滞留。